Clinical Trial Update: Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated monthly injections of risperidone for efficacy and safety in adults with schizophrenia or schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperidone long-acting injectable (Risperdal Consta) (Risperidone)

Snippet

Sponsor: Janssen, LP | Conditions: Schizophrenia, Psychotic Disorders | Phase 3 | Status: COMPLETED